Hypokalemia of newborn
ICD-10 P74.32 is a billable code used to indicate a diagnosis of hypokalemia of newborn.
Hypokalemia in newborns is characterized by low serum potassium levels, which can lead to various clinical manifestations including muscle weakness, respiratory distress, and cardiac arrhythmias. This condition is often transitory and can arise from several factors such as inadequate maternal potassium intake, excessive renal loss, or gastrointestinal losses. In neonates, hypokalemia may be exacerbated by conditions such as congenital adrenal hyperplasia or certain medications. Monitoring and managing electrolyte levels is crucial in the neonatal intensive care unit (NICU) setting, where infants are at higher risk due to their immature renal function and increased metabolic demands. Treatment typically involves potassium supplementation and addressing the underlying cause of the deficiency. It is essential for healthcare providers to recognize the signs and symptoms early to prevent complications associated with severe hypokalemia.
Detailed records of electrolyte levels, treatment protocols, and clinical observations.
Infants presenting with lethargy, poor feeding, or arrhythmias in the NICU.
Ensure accurate tracking of potassium supplementation and response to treatment.
Comprehensive history including maternal health and any medications taken during pregnancy.
Pediatric follow-up for infants discharged with a history of electrolyte imbalances.
Consideration of developmental milestones and ongoing monitoring of metabolic health.
Used for obtaining blood samples to monitor electrolyte levels in newborns.
Document the reason for blood draw and any relevant clinical findings.
Neonatologists should ensure that the procedure is justified based on clinical indicators.
Common causes include inadequate maternal potassium intake, renal losses, gastrointestinal losses, and certain medications. It's crucial to assess the infant's clinical history and laboratory results to determine the underlying cause.
